Linked Data API

Show Search Form

Search Results

882148
registered interest false more like this
date less than 2018-04-13more like thismore than 2018-04-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 March 2018 to Questions 134201, 134202 and 134203, on Prisoners: Hepatitis, if he will publish the Health and Justice Indicators of Performance data for the number of prisoners by prison that have (a) been tested for hepatitis C, (b) been diagnosed with hepatitis C and (c) received treatment for hepatitis C. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 135207 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-04-20more like thismore than 2018-04-20
answer text <p>Data collected via the Health and Justice Indicators of Performance is used by NHS England commissioners to performance manage healthcare providers in prisons. NHS England currently does not have plans to publish this data.</p><p> </p><p>Prison healthcare providers commissioned by NHS England are responsible for referring patients diagnosed with hepatitis C virus infection to specialist services for assessment and treatment.</p><p> </p><p>Public Health England is supporting a research study into barriers to accessing hepatitis C virus treatment for people in prison, due to be completed in September 2018. Identified issues to date include: length of stay in a specific prison; patient choice; development of referral pathways from prisons, and ‘run rates’ imposed on Operational Delivery Networks which limited the number of people treated per year</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN 135208 more like this
question first answered
less than 2018-04-20T11:00:49.78Zmore like thismore than 2018-04-20T11:00:49.78Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
882149
registered interest false more like this
date less than 2018-04-13more like thismore than 2018-04-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 March 2018 to Questions 134202 and 134203, on Prisoners: Hepatitis, for what reason 48 per cent of prisoners diagnosed with hepatitis C in the first quarter of 2017-18 have yet to be referred to specialist care to have their infection treated. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 135208 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-04-20more like thismore than 2018-04-20
answer text <p>Data collected via the Health and Justice Indicators of Performance is used by NHS England commissioners to performance manage healthcare providers in prisons. NHS England currently does not have plans to publish this data.</p><p> </p><p>Prison healthcare providers commissioned by NHS England are responsible for referring patients diagnosed with hepatitis C virus infection to specialist services for assessment and treatment.</p><p> </p><p>Public Health England is supporting a research study into barriers to accessing hepatitis C virus treatment for people in prison, due to be completed in September 2018. Identified issues to date include: length of stay in a specific prison; patient choice; development of referral pathways from prisons, and ‘run rates’ imposed on Operational Delivery Networks which limited the number of people treated per year</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN 135207 more like this
question first answered
less than 2018-04-20T11:00:49.86Zmore like thismore than 2018-04-20T11:00:49.86Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
872286
registered interest false more like this
date less than 2018-03-26more like thismore than 2018-03-26
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of for Health and Social Care, what estimate he has been made of the number of prisoners infected with the hepatitis C virus in each prison in each of the last three financial years. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 134200 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>Performance in relation to the blood borne virus opt-out testing programme in adult prisons in England, which includes hepatitis B, C and HIV, is measured at the prison level by NHS England through data collected as part of the Health and Justice Indicators of Performance (HJIPs).</p><p> </p><p>For financial years 2015/16, 2016/17 and quarter one of 2017/18 (the most current period for which published data is available), 11.5, 10.5 and 18.8% of new receptions and transfers to prisons in England have been tested for infection with hepatitis C virus.</p><p> </p><p>HJIP data on the number of tests undertaken for hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 8,797 tests were undertaken in prisons during that period.</p><p> </p><p>HJIP data on the number of prisoners diagnosed with hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that during this period 1,590 people tested positive for hepatitis C antibody, and of those 434 tested positive for hepatitis C virus as identified by polymerase chain reaction testing.</p><p> </p><p>HJIP data on the number of patients referred for treatment of hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 226 prisoners were referred into specialist care during this period to have their infection treated</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN
134201 more like this
134202 more like this
134203 more like this
question first answered
less than 2018-03-29T13:47:37.233Zmore like thismore than 2018-03-29T13:47:37.233Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
872287
registered interest false more like this
date less than 2018-03-26more like thismore than 2018-03-26
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made the number of prisoners that have been tested for the hepatitis C virus in each prison in each of the last three financial years. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 134201 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>Performance in relation to the blood borne virus opt-out testing programme in adult prisons in England, which includes hepatitis B, C and HIV, is measured at the prison level by NHS England through data collected as part of the Health and Justice Indicators of Performance (HJIPs).</p><p> </p><p>For financial years 2015/16, 2016/17 and quarter one of 2017/18 (the most current period for which published data is available), 11.5, 10.5 and 18.8% of new receptions and transfers to prisons in England have been tested for infection with hepatitis C virus.</p><p> </p><p>HJIP data on the number of tests undertaken for hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 8,797 tests were undertaken in prisons during that period.</p><p> </p><p>HJIP data on the number of prisoners diagnosed with hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that during this period 1,590 people tested positive for hepatitis C antibody, and of those 434 tested positive for hepatitis C virus as identified by polymerase chain reaction testing.</p><p> </p><p>HJIP data on the number of patients referred for treatment of hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 226 prisoners were referred into specialist care during this period to have their infection treated</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN
134200 more like this
134202 more like this
134203 more like this
question first answered
less than 2018-03-29T13:47:37.297Zmore like thismore than 2018-03-29T13:47:37.297Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
872288
registered interest false more like this
date less than 2018-03-26more like thismore than 2018-03-26
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of prisoners that have been diagnosed with the hepatitis C virus in each prison in each of the last three financial years. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 134202 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>Performance in relation to the blood borne virus opt-out testing programme in adult prisons in England, which includes hepatitis B, C and HIV, is measured at the prison level by NHS England through data collected as part of the Health and Justice Indicators of Performance (HJIPs).</p><p> </p><p>For financial years 2015/16, 2016/17 and quarter one of 2017/18 (the most current period for which published data is available), 11.5, 10.5 and 18.8% of new receptions and transfers to prisons in England have been tested for infection with hepatitis C virus.</p><p> </p><p>HJIP data on the number of tests undertaken for hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 8,797 tests were undertaken in prisons during that period.</p><p> </p><p>HJIP data on the number of prisoners diagnosed with hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that during this period 1,590 people tested positive for hepatitis C antibody, and of those 434 tested positive for hepatitis C virus as identified by polymerase chain reaction testing.</p><p> </p><p>HJIP data on the number of patients referred for treatment of hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 226 prisoners were referred into specialist care during this period to have their infection treated</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN
134200 more like this
134201 more like this
134203 more like this
question first answered
less than 2018-03-29T13:47:37.36Zmore like thismore than 2018-03-29T13:47:37.36Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
872289
registered interest false more like this
date less than 2018-03-26more like thismore than 2018-03-26
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis: Prisoners more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of prisoners that have received treatment for the hepatitis C virus in each prison in each of the last three financial years. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 134203 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>Performance in relation to the blood borne virus opt-out testing programme in adult prisons in England, which includes hepatitis B, C and HIV, is measured at the prison level by NHS England through data collected as part of the Health and Justice Indicators of Performance (HJIPs).</p><p> </p><p>For financial years 2015/16, 2016/17 and quarter one of 2017/18 (the most current period for which published data is available), 11.5, 10.5 and 18.8% of new receptions and transfers to prisons in England have been tested for infection with hepatitis C virus.</p><p> </p><p>HJIP data on the number of tests undertaken for hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 8,797 tests were undertaken in prisons during that period.</p><p> </p><p>HJIP data on the number of prisoners diagnosed with hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that during this period 1,590 people tested positive for hepatitis C antibody, and of those 434 tested positive for hepatitis C virus as identified by polymerase chain reaction testing.</p><p> </p><p>HJIP data on the number of patients referred for treatment of hepatitis C virus has only been published for quarter one of financial year 2017/18. This data indicates that 226 prisoners were referred into specialist care during this period to have their infection treated</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN
134200 more like this
134201 more like this
134202 more like this
question first answered
less than 2018-03-29T13:47:37.407Zmore like thismore than 2018-03-29T13:47:37.407Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
872290
registered interest false more like this
date less than 2018-03-26more like thismore than 2018-03-26
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hepatitis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans Public Health England has to update the template, Hepatitis C: commissioning template for estimating disease prevalence, published in March 2014. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 134204 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>Public Health England is working on providing updated estimates of hepatitis C (HCV) prevalence and disease burden at the sub-national level, covering the 22 Operational Delivery Network (ODN) areas that deliver HCV treatments in England.</p><p> </p><p>The new ODN HCV profile tool will make use of a broad range of HCV indicator data, including: surveillance data on HCV prevalence in people who inject drugs; the size of this key at-risk population; treatment and diagnoses, and; severe HCV-related liver disease. Modelling work is underway to link these data sources in a local ODN-level epidemic model, which will provide more robust estimates of prevalence, proportion diagnosed, future disease burden and projected impact of treatment for each ODN.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-03-29T13:49:28.35Zmore like thismore than 2018-03-29T13:49:28.35Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
869346
registered interest false more like this
date less than 2018-03-22more like thismore than 2018-03-22
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the effect of the UK leaving the EU on medical research into (a) rare and (b) paediatric cancers. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 133860 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>The Government’s commitment to funding cancer research has not changed because of the referendum.</p><p> </p><p>Rare and paediatric cancer research, along with all cancer research, is a strong priority for the Government including through the National Institute for Health Research, which has invested £745 million in cancer research from 2010/11 to 2015/16.</p><p> </p><p>My Rt. hon. Friend the Prime Minister has made it clear that we want to work closely with Europe in science and research, stating in a speech on 3 March: “the UK is also committed to establishing a far-reaching science and innovation pact with the EU, facilitating the exchange of ideas and researchers. This would enable the UK to participate in key programmes alongside our EU partners”.</p><p> </p><p>My Rt. hon. Friend the Chancellor has also said that the Treasury will guarantee EU structural and investment funding, promised before the Autumn Statement. He has also promised to underwrite payments for competitive EU funding awards through the Horizon 2020 underwrite guarantee, which was announced on 13 August 2016.</p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-03-29T11:13:40.92Zmore like thismore than 2018-03-29T11:13:40.92Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this
869347
registered interest false more like this
date less than 2018-03-22more like thismore than 2018-03-22
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Clinical Trials: EU Law more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what his policy is on alignment with the EU Clinical Trials Regulation after the UK leaves the EU. more like this
tabling member constituency Ealing, Southall more like this
tabling member printed
Mr Virendra Sharma more like this
uin 133861 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-27more like thismore than 2018-03-27
answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of exit negotiations is working to ensure that we have the best possible environment in which to support the United Kingdom medical research sector and patient access to cross-border clinical trials after we leave the EU.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU is yet to be set by the European Commission, but is expected to be in early 2020.</p><p> </p><p>Whatever the outcome of the UK’s EU exit negotiations, the current regulatory approval legislation will stay in place until such time as any changes are needed, so there will be no interruption in UK clinical trials approval. The EU Withdrawal Bill will make the current UK clinical trials regulations (2004 2001/1031) that implement the clinical trials directive (2001/20/EC) operable on exit day and this is not contingent on any decision about whether the CTR will apply in the future.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN 133956 more like this
question first answered
less than 2018-03-27T16:14:46.903Zmore like thismore than 2018-03-27T16:14:46.903Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1604
label Biography information for Mr Virendra Sharma more like this